Pharmaceutical IP and competition law in South Africa: overview

Published Date: May 12, 2020

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to pharmaceutical IP and competition law in South Africa.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

To read the full Q&A, visit Thomson Reuters Practical Law.

For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.

Alexis Apostolidis
Partner | Head of Competition Law Group
Danie Dohmen
Partner | Patent Attorney
Jenny Pienaar
Partner | Trade Mark Attorney

Related News & Insights

BIOPROSPECTING IN SOUTH AFRICA

Apr 22 2022 | Alexis Apostolidis, | Intellectual Property, | Patents,

INTRODUCTION South Africa has a biodiversity of 10% of the world’s plants; 7% of the world’s rep...

Pharmaceutical IP and competition law in South Africa: overview

May 12 2020 | Alexis Apostolidis, | Danie Dohmen, | Intellectual Property, | Jenny Pienaar, | Patents, | South Africa,

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Ale...